Company Filing History:
Years Active: 2022
Title: Robert Breese: Innovator in Mood Disorder Research
Introduction
Robert Breese is a notable inventor based in Patterson, NY (US). He has made significant contributions to the field of mood disorder research through his innovative work. His research focuses on developing animal models that can help in understanding human mood disorders.
Latest Patents
Breese holds a patent for a "Rodent model of mood disorders." This patent relates to an animal model of human diseases, specifically targeting mood disorders such as unipolar depression and anxiety disorders. The patent discloses genetically modified rodent animals that carry a humanized G protein-coupled receptor 156 (GPR156) gene. This gene encodes a mutant human GPR156 protein that includes Asp at an amino acid position corresponding to position 533 in a full-length wild type human GPR156 protein. Breese's work in this area is crucial for advancing the understanding of these complex disorders.
Career Highlights
Robert Breese is associated with Regeneran Pharmaceuticals, Inc., where he continues to contribute to innovative research. His work has garnered attention in the scientific community, particularly for its potential applications in treating mood disorders.
Collaborations
Breese collaborates with talented individuals in his field, including Meghan Drummond Samuelson and Brian Zambrowicz. These collaborations enhance the research efforts and contribute to the development of effective solutions for mood disorders.
Conclusion
Robert Breese is a pioneering inventor whose work on rodent models of mood disorders is paving the way for future research and treatment options. His contributions are vital in the ongoing quest to understand and address mental health challenges.